Peter Knighton
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Diabetes Management and Research
- Diabetes Treatment and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
Papers in
-
- Diabetes Management and Research 3
- Diabetes Treatment and Management 3
- Diabetes, Cardiovascular Risks, and Lipoproteins 2
- Diabetes Management and Education 2
-
- Chronic Disease Management Strategies 5
- Co-authors
- Jonathan Valabhji (10 shared papers)Naomi Holman (11 shared papers)Bob Young (11 shared papers)Kamlesh Khunti (9 shared papers)Naveed Sattar (9 shared papers)Partha Kar (6 shared papers)Emma Barron (6 shared papers)Chirag Bakhai (7 shared papers)
- Journals
- Diabetic Medicine (4 papers)The Lancet Diabetes & Endocrinology (3 papers)Diabetes Obesity and Metabolism (1 paper)Diabetes Care (1 paper)SSRN Electronic Journal (2 papers)
- Partner nations
- United KingdomUnited States
In The Last Decade
Peter Knighton
11 papers receiving 1.5k citations
Peter Knighton's Hit Papers
Peers
Comparison fields: 5 of 99
- Infectious Diseases 952
- Endocrinology, Diabetes and Metabolism 627
- Neurology 322
- Genetics 481
- Oncology 235
Countries citing papers authored by Peter Knighton
This map shows the geographic impact of Peter Knighton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Knighton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Knighton more than expected).
Fields of papers citing papers by Peter Knighton
This network shows the impact of papers produced by Peter Knighton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Knighton. The network helps show where Peter Knighton may publish in the future.
Co-authors
The 24 scholars most cited alongside Peter Knighton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study Hit paper breakdown → | 2020 | 639 |
| 2 | Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study Hit paper breakdown → | 2020 | 600 |
| 3 | 2021 | 123 | |
| 4 | 2022 | 32 | |
| 5 | 2022 | 26 | |
| 6 | 2021 | 25 | |
| 7 | 2020 | 24 | |
| 8 | 2021 | 20 | |
| 9 | 2020 | 16 | |
| 10 | 2022 | 5 | |
| 11 | 2022 | 4 |
About Peter Knighton
Peter Knighton is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology, Infectious Diseases, Genetics and Surgery, having authored 11 papers that have together received 1.5k indexed citations. Recurring topics across this work include Chronic Disease Management Strategies (5 papers), Diabetes Management and Research (3 papers), Diabetes Treatment and Management (3 papers), COVID-19 Clinical Research Studies (3 papers), Diabetes and associated disorders (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Obesity and Health Practices (2 papers) and Diabetes Management and Education (2 papers). The work is most often cited by research in Infectious Diseases (952 citations), Endocrinology, Diabetes and Metabolism (627 citations), Neurology (322 citations), Genetics (481 citations) and Oncology (235 citations). Peter Knighton has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include Jonathan Valabhji, Naomi Holman, Bob Young, Kamlesh Khunti, Naveed Sattar, Partha Kar, Emma Barron, Chirag Bakhai, Nicholas J. Wareham and Hassan Ismail. Their work appears in journals such as Diabetic Medicine, The Lancet Diabetes & Endocrinology, Diabetes Obesity and Metabolism, Diabetes Care and SSRN Electronic Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.